Ortho-Clinical Diagnostics Offers Complete Drugs-of-Abuse Panel With Addition Of Five New Assays (Medical News Today)
Ortho-Clinical Diagnostics, a Johnson & Johnson company, announces FDA 510(k) clearance and worldwide availability of five additional MicroTip assays for use in the diagnosis and treatment of drug use or overdose. The five new tests complete the menu of eight drugs-of-abuse assays now available for use on the Ortho-Clinical Diagnostics VITROS 5,1 FS Chemistry System. [click link for full ...

QUMAS and EXTEDO/IABG-LSS Deliver Integrated Document and Submission Management Solution to Intercell (Market Wire via Yahoo! Finance)
QUMAS, a leading provider of quality management and regulatory affairs solutions, today announced that biotechnology company Intercell AG has implemented the QUMAS Compliance Suite(TM) and the eCTDmanager Suite(TM) from EXTEDO/IABG Life Sciences Solutions.

Medical ads aim straight for the heart (Chicago Tribune)
An outcry over ads nudging consumers to ask their doctors for purple pills, depression remedies or other brand-name prescription drugs hasn't stopped an escalation of direct-to-consumer marketing in health care.